Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

39.52
Delayed Data
As of 4:00pm ET
 +0.01 / +0.03%
Today’s Change
25.98
Today|||52-Week Range
41.41
-1.69%
Year-to-Date
Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View
Jan 05 / Zacks.com - Paid Partner Content
Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging
Jan 05 / Zacks.com - Paid Partner Content
Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite
Jan 05 / Zacks.com - Paid Partner Content
ResMed Achieves Key Milestone in Sleep-Disordered Breathing
Jan 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close39.51
Today’s open39.74
Day’s range39.25 - 39.75
Volume177,624
Average volume (3 months)338,280
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-8.04%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.02%
P/E ratioNM
Price/Sales1.97
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
ICUIICU Medical Inc-0.25-0.19%
HYHHalyard Health Inc-0.27-0.70%
NXTMNxStage Medical Inc+0.26+0.94%
PENPenumbra Inc+0.10+0.14%
Data as of 4:02pm ET, 01/18/2017

Financials

Next reporting dateFebruary 6, 2017
EPS forecast (this quarter)$0.40
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Chief Financial Officer
William P. Burke
Corporate headquarters
Braintree, Massachusetts

Forecasts


Search for Jobs